<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000645.v2.p1" parentStudy="phs000645.v2.p1" createDate="2014-11-26" modDate="2014-11-26">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Michaela Frye, PhD</td><td>WT-MRC-Stem Cell Institute, Cambridge, UK</td></tr>
		<tr><td>Funding Source</td><td>Cancer Research UK: &quot;Cytosine-5 RNA methylation in normal and cancer stem cells&quot;</td><td>WT-MRC-Stem Cell Institute, Cambridge, UK</td></tr>
		<tr><td>Funding Source</td><td>European Research Council: &quot;m5C RNA&quot;</td><td>WT-MRC-Stem Cell Institute, Cambridge, UK</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Location and Function of Cytosine-5 Methylation in RNA</StudyNameEntrez>
	<StudyNameReportPage>Location and Function of NSun2-Mediated Cytosine-5 Methylation in RNA and its Effect on Translation</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Mutations in the cytosine-5 RNA methyltransferase NSun2 can cause neurodevelopmental disorders and symptoms commonly found in patients with Dubowitz-like syndrome. Some tRNAs are known to be methylated NSun2, however the occurrence of cytosine-5 methylation (m<sup>5</sup>C) in other RNA biotypes is still under debate. Location in RNA and function of m<sup>5</sup>C has not been studied yet. This study is aimed at identifying new m<sup>5</sup>C methylated RNA biotypes, as well as the location at specific structures or sequences and the ultimate biological function. The impact of the loss of NSun2-mediated methylation is also determined by comparing gene expression data with the global cytosine-5 RNA methylome in Dubowitz-like syndrome patients. We also use ribosomal profiling to assess the impact of the loss and rescue of Nsun2-mediated cytosine-5 RNA methylation on translation rates and ribosome occupancy.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Please refer to study "Ciliopathies Exome Sequencing Initiative" (dbGaP Study Accession: <a href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000288.v1.p1">phs000288.v1.p1</a>)</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="22577224"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22541562"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22541559"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23604283"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23681756"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Dubowitz Syndrome"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Michaela Frye, PhD</AttName>
			<Institution>WT-MRC-Stem Cell Institute, Cambridge, UK</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Cancer Research UK: &quot;Cytosine-5 RNA methylation in normal and cancer stem cells&quot;</AttName>
			<Institution>WT-MRC-Stem Cell Institute, Cambridge, UK</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>European Research Council: &quot;m5C RNA&quot;</AttName>
			<Institution>WT-MRC-Stem Cell Institute, Cambridge, UK</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>March 2012 - Release of Ciliopathies Exome Sequencing Initiative (dbGaP Study Accession: <a href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000288.v1.p1">phs000288.v1.p1</a>)</p> <p>June 2012 - Publication of the study Martinez FJ, Lee JH, et al. Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome. J Med Genet. 2012 Jun;49(6):380-5 (<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22577224">PMID: 22577224</a>).</p> <p>November 2014 - Submission of additional data to dbGaP.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NICHD</DacName>
      <DacFullName>NICHD-DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000645.v2.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000645.v2.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000645.v2.p1" FileName="Loss_of_tRNA_methylation_in_Dubowitz-like_Syndrome_DUC-Frye-fina-3-18-13.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
